Mangalam Drugs & Organics Ltd Sustainability Reports

Mangalam Drugs & Organics Limited manufactures and sells active pharmaceutical ingredients (APIs) and chemical intermediates. The company specializes in frontline anti-malarial therapies along with other multi-product therapeutic classes.

Sector: Manufacturing

Country: India

Exchange: Bombay Stock Exchange

LEI: 335800BUEKMHUYDDNO02

FIGI: BBG001SNG8M7

15 reports from 2008 to 2025

• Mangalam Drugs & Organics Ltd 2025 Annual Report
• Mangalam Drugs & Organics Ltd 2022 Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and Immediate Relatives of Designated Persons in the Securities
• Mangalam Drugs & Organics Ltd 2021 Annual Report
• Mangalam Drugs & Organics Ltd 2020 Annual Report
• Mangalam Drugs & Organics Ltd 2019 Annual Report